Cargando…
The Prevalence of the Potential Drug-Drug Interactions Involving Anticancer Drugs in China: A Retrospective Study
BACKGROUND: To survey the prevalence of potential drug-drug interactions (DDIs) between anticancer drugs and non-anticancer drugs and evaluate the risk factors associated with these drug-drug interactions in China. METHODS: All discharged patients in the Department of Oncology were collected from Ju...
Autores principales: | WANG, Weilan, XIAO, Bingkun, LIU, Ziqi, WANG, Dongxiao, ZHU, Man |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570793/ https://www.ncbi.nlm.nih.gov/pubmed/31223570 |
Ejemplares similares
-
Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
por: WANG, Weilan, et al.
Publicado: (2013) -
Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs
por: van Leeuwen, R W F, et al.
Publicado: (2013) -
Prevalence of potential drug–drug interactions in outpatients of a general hospital in China: a retrospective investigation
por: Ren, Weifang, et al.
Publicado: (2020) -
Prevalence of Potential Drug-Drug Interactions Involving Antiretroviral Drugs in a Large Kenyan Cohort
por: Kigen, Gabriel, et al.
Publicado: (2011) -
Involvement of Transporters in Intestinal Drug–Drug Interactions of Oral Targeted Anticancer Drugs Assessed by Changes in Drug Absorption Time
por: Malnoë, David, et al.
Publicado: (2022)